Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa Innao

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Clinical Case Reports|May 21, 2026
Successful Treatment of Evans Syndrome Onset With Zanubrutinib in Combination With Romiplostim During Venetoclax Treatment in a Patient With Chronic Lymphocytic Leukemia: A Case ReportVanessa Innao, Alessia Paola Maria Barbagallo, Oriana Bianco, et al.
Leukemia Research|February 15, 2017
Telomerase and telomere biology in hematological diseases: A new therapeutic targetAlessandro Allegra, Vanessa Innao, Giuseppa Penna, et al.
Cancer Investigation|April 17, 2018
Nanobodies and Cancer: Current Status and New PerspectivesAlessandro Allegra, Vanessa Innao, Demetrio Gerace, et al.
Mediators of Inflammation|November 2, 2017
Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple MyelomaCaterina Musolino, Alessandro Allegra, Vanessa Innao, et al.
Critical Reviews in Oncology/Hematology|July 1, 2015
Vaccination of multiple myeloma: Current strategies and future prospectsAlessandro Allegra, Giuseppa Penna, Vanessa Innao, et al.
International Journal of Molecular Sciences|October 27, 2019
The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 ParadoxAlessandro Allegra, Vanessa Innao, Gennaro Tartarisco, et al.
Cancer Investigation|September 26, 2014
The cancer stem cell hypothesis: a guide to potential molecular targetsAlessandro Allegra, Andrea Alonci, Giuseppa Penna, et al.
Leukemia Research|November 19, 2013
New orally active proteasome inhibitors in multiple myelomaAlessandro Allegra, Andrea Alonci, Demetrio Gerace, et al.
Expert Review of Hematology|March 5, 2020
Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematologyAlessandro Allegra, Vanessa Innao, Giorgio Basile, et al.
International Journal of Molecular Sciences|June 2, 2021
Reviewing the Significance of Vitamin D Substitution in Monoclonal GammopathiesVanessa Innao, Alessandro Allegra, Lia Ginaldi, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Clinical Case Reports|May 21, 2026
Successful Treatment of Evans Syndrome Onset With Zanubrutinib in Combination With Romiplostim During Venetoclax Treatment in a Patient With Chronic Lymphocytic Leukemia: A Case ReportVanessa Innao, Alessia Paola Maria Barbagallo, Oriana Bianco, et al.
Leukemia Research|February 15, 2017
Telomerase and telomere biology in hematological diseases: A new therapeutic targetAlessandro Allegra, Vanessa Innao, Giuseppa Penna, et al.
Cancer Investigation|April 17, 2018
Nanobodies and Cancer: Current Status and New PerspectivesAlessandro Allegra, Vanessa Innao, Demetrio Gerace, et al.
Mediators of Inflammation|November 2, 2017
Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple MyelomaCaterina Musolino, Alessandro Allegra, Vanessa Innao, et al.
Critical Reviews in Oncology/Hematology|July 1, 2015
Vaccination of multiple myeloma: Current strategies and future prospectsAlessandro Allegra, Giuseppa Penna, Vanessa Innao, et al.
International Journal of Molecular Sciences|October 27, 2019
The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 ParadoxAlessandro Allegra, Vanessa Innao, Gennaro Tartarisco, et al.
Cancer Investigation|September 26, 2014
The cancer stem cell hypothesis: a guide to potential molecular targetsAlessandro Allegra, Andrea Alonci, Giuseppa Penna, et al.
Leukemia Research|November 19, 2013
New orally active proteasome inhibitors in multiple myelomaAlessandro Allegra, Andrea Alonci, Demetrio Gerace, et al.
Expert Review of Hematology|March 5, 2020
Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematologyAlessandro Allegra, Vanessa Innao, Giorgio Basile, et al.
International Journal of Molecular Sciences|June 2, 2021
Reviewing the Significance of Vitamin D Substitution in Monoclonal GammopathiesVanessa Innao, Alessandro Allegra, Lia Ginaldi, et al.
Pageof 7